Estrella Immunopharma Inc (ESLA)
$1.015
Market is closed - opens 7 PM, 23 May 2024
Performance
- $0.98$1.04$1.01
2.96%
Downside
Day's Volatility :5.3%
Upside
2.42%
- $0.86$33.00$1.01
14.85%
Downside
52 Weeks Volatility :97.39%
Upside
96.94%
Returns
| Period | Estrella Immunopharma Inc | Index (Russel 2000) |
|---|---|---|
3 Months | 3.96% | 0.0% |
6 Months | -25.53% | 0.0% |
1 Year | -69.74% | 0.0% |
3 Years | -69.74% | -20.1% |
Highlights
Market Capitalization | 42.9M |
Book Value | $0.29 |
Earnings Per Share (EPS) | -0.2 |
Profit Margin | 0.0% |
Operating Margin TTM | 0.0% |
Return On Assets TTM | -41.46% |
Return On Equity TTM | -179.6% |
Revenue TTM | 0.0 |
Revenue Per Share TTM | 0.0 |
Quarterly Revenue Growth YOY | 0.0% |
Gross Profit TTM | 0.0 |
Diluted Eps TTM | -0.2 |
Quarterly Earnings Growth YOY | 0.0 |
EPS Estimate Current Year | 0.0 |
EPS Estimate Next Year | 0.0 |
EPS Estimate Current Quarter | 0.0 |
EPS Estimate Next Quarter | 0.0 |
Analyst Recommendation
Technicals Summary
Sell
Neutral
Buy
Estrella Immunopharma Inc is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.
Peers
| Company Name | 1 Month | 6 Month | 1 Year | 3 Years | 5 Years |
|---|---|---|---|---|---|
 Estrella Immunopharma Inc | -1.41% | -25.53% | -69.74% | -69.74% | -69.74% |
 Moderna, Inc. | 37.56% | 83.82% | 13.37% | -12.47% | 553.14% |
 Regeneron Pharmaceuticals, Inc. | 10.42% | 24.29% | 32.26% | 98.6% | 210.52% |
 Novo Nordisk A/s | 7.9% | 30.89% | 58.53% | 230.87% | 458.51% |
 Vertex Pharmaceuticals Incorporated | 10.52% | 25.13% | 30.01% | 109.26% | 156.43% |
| Company Name | P/E Ratio | P/B Ratio | PEG Ratio | EPS | ROE | ROA | Div Yield | BVPS |
|---|---|---|---|---|---|---|---|---|
Estrella Immunopharma Inc | NA | NA | NA | 0.0 | -1.8 | -0.41 | NA | 0.29 |
Moderna, Inc. | 24.73 | NA | 0.0 | -6.46 | -0.38 | -0.16 | NA | 33.47 |
Regeneron Pharmaceuticals, Inc. | 29.16 | 29.16 | 1.46 | 44.2 | 0.15 | 0.08 | NA | 250.15 |
Novo Nordisk A/s | 45.83 | 45.83 | 2.36 | 3.5 | 1.0 | 0.25 | 0.01 | 22.18 |
Vertex Pharmaceuticals Incorporated | 28.9 | 28.9 | 0.53 | 17.11 | 0.24 | 0.13 | NA | 71.8 |
| Company Name | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin |
|---|---|---|---|---|---|
Estrella Immunopharma Inc | NA | $42.9M | -69.74% | NA | 0.0% |
Moderna, Inc. | Buy | $54.0B | 553.14% | 24.73 | -115.82% |
Regeneron Pharmaceuticals, Inc. | Buy | $108.8B | 210.52% | 29.16 | 29.45% |
Novo Nordisk A/s | Buy | $592.1B | 458.51% | 45.83 | 36.55% |
Vertex Pharmaceuticals Incorporated | Buy | $115.1B | 156.43% | 28.9 | 39.46% |
Company Information
Organization | Estrella Immunopharma Inc |
Employees | 0 |
CEO | Dr. Cheng Liu Ph.D. |
Industry | Miscellaneous |
Discover More
A Spac I Acquisition Corp
$1.02
-3.33%
Keyarch Acquisition Corp
$1.02
-3.33%
Connexa Sports Technologies Inc
$1.02
-3.33%
Us Value Etf
$1.02
-3.33%
First Wave Biopharma Inc
$1.02
-3.33%
Global X Msci Next Emerging
$1.02
-3.33%
Fat Projects Acquisition Corp
$1.02
-3.33%
Ishares Intl Div Growth Etf
$1.02
-3.33%
Corsair Gaming, Inc.
$1.02
-3.33%